PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23607370-13	2013	The systemic inflammatory response triggered by intestinal IRI was significantly attenuated in mice pretreated with remifentanil (159 vs 805 pg/ml of IL-6 after saline pretreatment, with 92 pg/ml in the sham groups).	Remifentanil	116-128	interleukin 6	Mus musculus	150-154	
30167784-0	2018	Remifentanil suppresses increase in interleukin-6 mRNA in the brain by inhibiting cyclic AMP synthesis.	Remifentanil	0-12	interleukin 6	Mus musculus	36-49	
30167784-9	2018	RESULTS: Remifentanil suppressed increase in IL-6 mRNA levels in the mouse brain, and also inhibited the responses of plasma IL-6, corticosterone, and noradrenaline in an inflammatory state.	Remifentanil	9-21	interleukin 6	Mus musculus	45-49	
30167784-9	2018	RESULTS: Remifentanil suppressed increase in IL-6 mRNA levels in the mouse brain, and also inhibited the responses of plasma IL-6, corticosterone, and noradrenaline in an inflammatory state.	Remifentanil	9-21	interleukin 6	Mus musculus	125-129	
30167784-11	2018	In cultured cells, remifentanil suppressed increase in IL-6 mRNA levels and intracellular cAMP levels after the administration of LPS, and this enhanced IL-6 mRNA expression in response to LPS.	Remifentanil	19-31	interleukin 6	Mus musculus	55-59	
30167784-11	2018	In cultured cells, remifentanil suppressed increase in IL-6 mRNA levels and intracellular cAMP levels after the administration of LPS, and this enhanced IL-6 mRNA expression in response to LPS.	Remifentanil	19-31	interleukin 6	Mus musculus	153-157	
30167784-12	2018	CONCLUSION: Remifentanil suppressed increase in IL-6 mRNA levels in the brain in an inflammatory state, and this effect may be attributed to its direct action on neuronal cells through the inhibition of intracellular cAMP rather than corticosterone.	Remifentanil	12-24	interleukin 6	Mus musculus	48-52